Literature DB >> 12962800

Liver ischemic preconditioning: a new strategy for the prevention of ischemia-reperfusion injury.

C Peralta1, A Serafin, L Fernández-Zabalegui, Z Y Wu, J Roselló-Catafau.   

Abstract

Ischemic preconditioning renders the liver more tolerant to ischemia-reperfusion injury in warm and cold ischemia-reperfusion models. In general, the application of a 5 to 10-minute period of ischemia followed by 10 minutes of reperfusion confers early effective protection to the liver. Mechanisms responsible for this endogenous protective effect include: (1) transient nitric oxide production during liver preconditioning; (2) diminution of toxic reactive species generated on reperfusion; (3) remote effect on extrahepatic organs such as lung, kidney, and pancreas; (4) preservation of energy metabolism during ischemia; and (5) involvement of nuclear transcription factor and others.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12962800     DOI: 10.1016/s0041-1345(03)00571-2

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  10 in total

Review 1.  Cardioprotective effects of nitrite during exercise.

Authors:  John W Calvert
Journal:  Cardiovasc Res       Date:  2010-09-27       Impact factor: 10.787

2.  Involvement of glycogen synthase kinase-3β in liver ischemic conditioning induced cardioprotection against myocardial ischemia and reperfusion injury in rats.

Authors:  Shuai Yang; Geoffrey W Abbott; Wei Dong Gao; Jin Liu; Chaozhi Luo; Zhaoyang Hu
Journal:  J Appl Physiol (1985)       Date:  2017-02-02

3.  Modulation of liver oxidant-antioxidant system by ischemic preconditioning during ischemia/reperfusion injury in rats.

Authors:  Guang-Jin Yuan; Jin-Chun Ma; Zuo-Jiong Gong; Xiao-Mei Sun; Shi-Hua Zheng; Xi Li
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

4.  Essential role of the redox-sensitive kinase p66shc in determining energetic and oxidative status and cell fate in neuronal preconditioning.

Authors:  Jacquelynn E Brown; Stephanie L H Zeiger; Jane C Hettinger; Joshua D Brooks; Benjamin Holt; Jason D Morrow; Erik S Musiek; Ginger Milne; Bethann McLaughlin
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

5.  Ischemic preconditioning promotes intrinsic vascularization and enhances survival of implanted cells in an in vivo tissue engineering model.

Authors:  Shiang Y Lim; Sarah T Hsiao; Zerina Lokmic; Priyadharshini Sivakumaran; Gregory J Dusting; Rodney J Dilley
Journal:  Tissue Eng Part A       Date:  2012-07-11       Impact factor: 3.845

6.  Increased antioxidant capacity of serum did not prevent lipid peroxidation in the intermittent ischemia-reperfusion of rat small intestine.

Authors:  Hana Cizova; Ivana Papezikova; Lukas Kubala; Antonin Lojek; Milan Ciz
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

7.  Use of lung allografts from brain-dead donors after cardiopulmonary arrest and resuscitation.

Authors:  Anthony W Castleberry; Mathias Worni; Asishana A Osho; Laurie D Snyder; Scott M Palmer; Ricardo Pietrobon; R Duane Davis; Matthew G Hartwig
Journal:  Am J Respir Crit Care Med       Date:  2013-08-15       Impact factor: 21.405

8.  Remote Liver Ischemic Preconditioning Protects against Sudden Cardiac Death via an ERK/GSK-3β-Dependent Mechanism.

Authors:  Zhaoyang Hu; Sheng Hu; Shuai Yang; Mou Chen; Ping Zhang; Jin Liu; Geoffrey W Abbott
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

9.  Protective Effects of Adenosine Receptor Agonist in a Cirrhotic Liver Resection Model.

Authors:  Emil Iskandarov; Pramod Kadaba Srinivasan; Wang Xin; Christian Bleilevens; Mamdouh Afify; Astrit Hamza; Lai Wei; Koichiro Hata; Boyukkishi Agayev; Rene Tolba
Journal:  Hepat Mon       Date:  2016-07-24       Impact factor: 0.660

10.  Preconditioning boosts regenerative programmes in the adult zebrafish heart.

Authors:  Anne-Sophie de Preux Charles; Thomas Bise; Felix Baier; Pauline Sallin; Anna Jaźwińska
Journal:  Open Biol       Date:  2016-07       Impact factor: 6.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.